People infected with COVID-19 experience a wide range of symptoms and severities, the most commonly reported including high fevers and respiratory problems. However, autopsy and other studies have also revealed that the infection ...
Jan 12, 2021
0
182
The measles-mumps-rubella (MMR) vaccine has been theorized to provide protection against COVID-19. In a new study published in mBio, an open-access journal of the American Society for Microbiology, researchers provide further ...
Nov 20, 2020
0
509
In the absence of approved, effective treatments for COVID-19, some hospitals have been treating patients with severe COVID symptoms with blood plasma from recovering patients. The blood of recovered patients contains antibodies ...
Oct 16, 2020
0
49
Seasonal colds are by all accounts no fun, but new research suggests the colds you've had in the past may provide some protection from COVID-19. The study, authored by infectious disease experts at the University of Rochester ...
Sep 29, 2020
0
68
Although people of any age can become infected with SARS-CoV-2, the virus that causes COVID-19, elderly patients face a higher risk of severity and death than younger patients. New research comparing the immune response among ...
Sep 21, 2020
0
4
University of Otago researchers have learnt more about how viruses operate and can evade the immune system and are now using their discovery to help learn more about COVID-19.
Aug 13, 2020
0
426
A newly discovered mechanism at work in human immunodeficiency virus (HIV) patients may also lead to new treatments for COVID-19, according to a team of researchers at the University of Alberta.
Jul 31, 2020
0
928
The bacterium Helicobacter pylori colonizes the stomach in half of the world's population and increases the risk of gastric cancer.
Jul 24, 2020
0
2
According to findings published this week in mBio, Nissle, a strain of Escherichia coli, is harmless to intestinal tissue and may protect the gut from enterohemorrhagic E. coli, a pathogen that produces Shiga toxin.
Jul 7, 2020
0
3
NIH investigators and colleagues have discovered that when the immune system first responds to infectious agents such as viruses or bacteria, a natural brake on the response prevents overactivation. Their new study in mBio ...
Jun 23, 2020
0
3
